The flavonoid silymarin and one of its structural components, silibinin, are substances with documented hepatoprotective properties. Their mechanisms of action are still poorly understood.

[15] Another two interesting studies are reported in the review by Flora et al. [71] The first study was performed in 2637 patients with chronic liver disease, treated with high doses of silymarin ...

Pharm Year 4 Student, Rakcops, Rakmhsu, Pharma Student, Ras Al Khaimah, United Arab Emirates 4 Faculty Supervisors ... This study aimed to investigate the hepatoprotective potential of dapagliflozin ...